期刊文献+

人脐带间充质干细胞治疗失代偿期肝硬化的近期效果 被引量:3

Short-term effects of human umbilical cord-derived mesenchymal stem cells in treatment of patients with decompensated cirrhosis
下载PDF
导出
摘要 背景:脐带间充质干细胞可分化为肝细胞样细胞。目的:观察人脐带间充质干细胞移植治疗失代偿期肝硬化的近期临床效果。方法:选择肝硬化失代偿期患者30例,对照组18例给予内科常规治疗,移植组12例在内科综合治疗基础上经肝动脉移植人脐带间充质干细胞悬液治疗。结果与结论:移植后,移植组白蛋白有上升趋势,从第2周开始明显高于对照组(P<0.05),并持续至第12周;谷丙转氨酶和凝血酶原时间有下降趋势,从第8周开始明显低于对照组(P<0.05),并持续至第12周;总胆红素水平有下降趋势,从第4周开始明显低于对照组(P<0.05),并持续至第12周。两组临床症状、体征改善情况差异无显著性意义(P>0.05)。说明经股动脉移植人脐带间充质干细胞是治疗失代偿期肝硬化近期有效。 BACKGROUND:Umbilical cord-derived mesenchymal stem cells(UCMSCs) can differentiate into hapatocyte-like cells.OBJECTIVE:To investigate short-time clinical effects of UCMSCs transplantation in treatment of patients with decompensated cirrhosis.METHODS:Thirty patients with decompensated cirrhosis were involved.Eighteen patients in the control group were treated with conventional therapy,while twelve patients in the transplantation group were treated with UCMSCs transplantation via hepatic artery based on conventional therapy.RESULTS AND CONCLUSION:After transplantation,albumin level in the transplantation group showed an ascend trend and had a significant increase(P 0.05) compared with the control group from 2 weeks to 12 weeks of transplantation.Meanwhile,both alanine aminotransferase and prothrombin time levels began to decrease at 2 weeks after transplantation and were significantly lower than those of the control group(P 0.05) from 8 weeks to 12 weeks of transplantation.In contrast to the controls,the level of total bilirubin in the transplantation group showed an ascend trend and had a significant increase(P 0.05) from 4 weeks to 12 weeks of transplantation.The differences in clinical symptoms and signs between the two groups were not significant(P 0.05).The transplantation of UC-MSCs via hepatic artery is effective in short time for treatment of patients with decompensated cirrhosis.
出处 《中国组织工程研究》 CAS CSCD 2012年第14期2585-2588,共4页 Chinese Journal of Tissue Engineering Research
基金 吴阶平医学基金会资助项目(320.6710.10001)~~
  • 相关文献

参考文献19

  • 1Lee OK,Kuo TK,Chen WM. Isolation of multipotent mesenchymal stem cells from umbilical cord blood[J].Blood,2004,(05):1669-1675.
  • 2Ohgushi H,Caplan AI. Stem cell technology and bioceramics:from cell to gene engineering[J].Journal of Biomedical Materials Research,1999,(06):913-927.
  • 3Erices A,Conget P,Minguell JJ. Mesenchymal progenitor cells in human umbilical cord blood[J].British Journal of Haematology,2000,(01):235-242.
  • 4熊中华,许倩,陆德云,王丽春,刘聪,赵连三.冻存人脐血间充质干细胞向类肝细胞的诱导分化[J].中国组织工程研究与临床康复,2007,11(7):1252-1255. 被引量:17
  • 5Zhao Q,Ren H,Li X. Differentiation of human umbilical cord mesenchymal stromal cells into low immunogenic hepatocyte-like cells[J].Cytotherapy,2009,(04):414-426.
  • 6Sarin SK,Kumar A,Almeida JA. Acute-on-chronic liver failure:consensus recommendations of the Asian Pacific Association for the study of the liver (APASL)[J].Hapatol Int,2009,(01):269-282.doi:10.1007/s12072-008-9106-x.
  • 7陆再英;钟南山;谢毅.内科学[M]北京:人民卫生出版社,2008446-456.
  • 8Sun L,Wang D,Liang J. Umbilical cord mesenchymal stem cell transplantation in severe and refractory systemic lupus erythematosus[J].Arthritis and Rheumatism,2010,(08):2467-2475.
  • 9Kern S,Eichler H,Stoeve J. Comparative analysis of mesenchymal stem cells from bone marrow,umbilical cord blood,or adipose tissue[J].Stem Cells,2006,(05):1294-1301.doi:10.1634/stemcells.2005-0342.
  • 10董毅,朱太岗,张飞虎,汤继春,葛曦,李月红,刘连成.自体外周血干细胞治疗肝硬化35例疗效分析[J].中华全科医学,2011,9(1):29-30. 被引量:8

二级参考文献102

共引文献56

同被引文献62

  • 1单云峰,周伟平,杨文,刘淑琴,曹惠芳,邱秀华,吴孟超,王红阳.大鼠肝卵圆细胞的分离培养和体外分化研究[J].中华实验外科杂志,2005,22(8):925-926. 被引量:18
  • 2姚鹏,胡大荣,王帅,闻炜,周一鸣,龚丽娟.自体骨髓干细胞移植治疗慢性肝衰竭研究[J].肝脏,2005,10(3):171-173. 被引量:60
  • 3曹葆强,林继宗,钟跃思,黄绍斌,林楠,汤照峰,吴祥元,项鹏,许瑞云.自体骨髓细胞经门静脉移植治疗肝硬化与肝功能不全的临床研究[J].中华普通外科杂志,2007,22(5):386-389. 被引量:23
  • 4Zimmermann A. Liver regeneration:the emergence of new pathways[J]. Med Sci Monit, 2002, 8(3): RA53 -63.
  • 5Fujikawa T, Hirose T, Fujii H, et al. Purification or adult hepatic pro - genitor cells using green fluorescence protein (GFP) - transgenic mice and fluorescence -activated cell sorting[J]. J Hepatol, 2003, 39(2): 162-170.
  • 6Dan YY, Yeoh GC. Liver stem cells, a scientific and clinical per-spective[J]. J Gastroenterol Hepatol, 2008, 23(5): 687 -698.
  • 7Burr RK, Loh Y, Pearce W, et al. Clinical applications of blood -derived and marrow -derived stem cells for nonmalignant diseases[J]. JAMA, 2008, 299(8): 925 -936.
  • 8Dominici M, Le Blanc K, Mueller I, et al. Minimal criteria for defining multipotent mesenchymal stromal cells. The international society for cellular therapy position statement[J]. Cytotherapy, 2006, 8(4): 315 -317.
  • 9Srivastava D, Ivey KN. Potential of stem -cell -based therapies for heart disease[J]. Nature, 2006, 441 (7097): 1097 -1099.
  • 10Cantz T, Manns MP, Ott M. Stem ceils in liver regeneration and therapy[J]. Cell Tissue Res, 2008,331 ( 1 ) : 271 -282.

引证文献3

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部